ProfileGDS5678 / 1427404_x_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 98% 98% 97% 97% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 19.750898
GSM967853U87-EV human glioblastoma xenograft - Control 29.8099898
GSM967854U87-EV human glioblastoma xenograft - Control 39.6222597
GSM967855U87-EV human glioblastoma xenograft - Control 49.7418597
GSM967856U87-EV human glioblastoma xenograft - Control 510.109198
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 19.9504298
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 29.9190498
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 39.9965298
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 410.031198
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 19.8040398
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 29.7667598
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 39.7744898
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 49.9065398
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 59.8973698